These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 911413)

  • 1. [Relationship between quality and serum level after the oral administration of commercial erythromycin tablets in man (author's transl)].
    Watanabe Y; Sano M; Motohashi K; Yoneda R; Mitsui Y
    Yakugaku Zasshi; 1977 Jul; 97(7):791-800. PubMed ID: 911413
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of dissolving pH of enteric coating agent on bioavailability of enteric coated tablets of erythromycin in man (author's transl)].
    Watanabe Y; Sano M; Motohashi K; Yoneda R
    Yakugaku Zasshi; 1978 Aug; 98(8):1092-100. PubMed ID: 30834
    [No Abstract]   [Full Text] [Related]  

  • 3. [Erythromycin: serum and urine levels following rectal administration (author's transl)].
    Tarsi R; Vitali C
    Ann Sclavo; 1976; 18(4):601-14. PubMed ID: 1020971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of meal on the plasma concentration of patients received repeated administration of OE-7, erythromycin stearate capsules (author's transl)].
    Yamashita T; Tsubura E
    Jpn J Antibiot; 1977 Jul; 30(7):517-20. PubMed ID: 909141
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relation between serum level in human and dissolution rate of commercial chloramphenicol tablets (author's transl)].
    Watanabe Y; Motohashi K; Mitsui Y; Yoneda R; Tanaka Y
    Yakugaku Zasshi; 1976 Dec; 96(12):1468-77. PubMed ID: 1035629
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute male gonorrhoea and single-dose per os treatment with erythromycin (author's transl)].
    Klíma J
    Cesk Dermatol; 1981 Feb; 56(1):37-42. PubMed ID: 7214558
    [No Abstract]   [Full Text] [Related]  

  • 7. [A double-blind comparison of josamycin propionate and erythromycin ethylsuccinate in the treatment of scarlet fever with their oral suspension preparations (author's transl)].
    Nakamizo Y; Akiba T; Tomizawa I; Tsuji M; Sato M
    Jpn J Antibiot; 1974 Apr; 27(2):73-85. PubMed ID: 4603299
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of serum erythromycin concentration following administration of 100 mg erythromycin ethyl succinate intramuscularly and 500 mg erythromycin stearate orally.
    McGimpsey JG; Webb CH; McCrea PH
    Int J Oral Surg; 1981; 10(Suppl 1):198-202. PubMed ID: 6807878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythromycin levels in serum during treatment with erythromycin stearate and base.
    Saarni H; Kanto J; Allonen H
    Ann Clin Res; 1979 Oct; 11(5):196-8. PubMed ID: 397800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the absorption of the combined administration of erythromycin and bromohexine hydrochloride].
    Höffler D; Nebe K; Wiethoff EO
    Arzneimittelforschung; 1972 Jan; 22(1):97-100. PubMed ID: 5067008
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood concentration and urinary excretion in human of OE-7, a gastric hard capsule containing enteric-coated granules. I (author's transl)].
    Yamashita T; Tsubura E; Fukuda T
    Jpn J Antibiot; 1976 Feb; 29(2):201-6. PubMed ID: 1263346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromycin pharmacokinetics in man.
    Houin G; Tillement JP; Lhoste F; Rapin M; Soussy CJ; Duval J
    J Int Med Res; 1980; 8 Suppl 2():9-14. PubMed ID: 7429008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption of erythromycin. A cross-over study in healthy volunteers.
    Männistö P; Tuomisto J; Räsänen R
    Arzneimittelforschung; 1975 Nov; 25(11):1828-31. PubMed ID: 1106445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tissue penetration of erythromycin (author's transl)].
    Dette GA
    Infection; 1979; 7(3):129-45. PubMed ID: 478653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of erythromycin after intravenous, intramuscular and oral administration to cats.
    Albarellos GA; Montoya L; Landoni MF
    Vet J; 2011 Jan; 187(1):129-32. PubMed ID: 19854664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bioavailability of erythromycin stearate versus enteric-coated erythromycin base when taken immediately before and after food.
    Clayton D; Leslie A
    J Int Med Res; 1981; 9(6):470-7. PubMed ID: 7319133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of in vivo bioavailability of erythromycin stearate tablets with in vitro tests.
    Stavchansky S; Doluisio JT; Martin A; Martin C; Cabana B; Dighe S; Loper A
    J Pharm Sci; 1980 Nov; 69(11):1307-10. PubMed ID: 7452460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparison of patient tolerance to enteric-coated vs nonenteric-coated erythromycin.
    Ellsworth AJ; Christensen DB; Volpone-McMahon MT
    J Fam Pract; 1990 Sep; 31(3):265-70. PubMed ID: 2202773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the development of an oral preparation of meproscillarin (author's transl)].
    Einig H; Mayer D
    Arzneimittelforschung; 1978; 28(3a):527-31. PubMed ID: 580583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bioavailability of erythromycin and colistin in calves (author's transl)].
    Escoula L; Coste M; Larrieu G
    Ann Rech Vet; 1981; 12(3):321-6. PubMed ID: 7344563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.